Patents by Inventor Zeni Alfonso

Zeni Alfonso has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170296697
    Abstract: Described herein are compositions and methods for the mitigation of burn progression. In particular, the described herein are compositions including regenerative cells for use in preventing and reducing burn progression. Also described are compositions and methods for improving graft take and healing, and preventing and/or treating hypertrophic scars.
    Type: Application
    Filed: October 2, 2015
    Publication date: October 19, 2017
    Inventors: John K. Fraser, Philippe Foubert, Zeni Alfonso
  • Publication number: 20170114325
    Abstract: Aspects of the invention provides methods for preparing and using adipose-tissue-derived stem and progenitor cells, adipose-tissue-derived lymphatic endothelial cells, and cells capable of differentiating into lymphatic endothelial cells to treat disorders of the lymphatic system and to modulate expansion, repair, and/or regeneration of the lymphatic system. The invention further provides using adipose-tissue-derived lymphatic endothelial cells and cells capable of differentiating into lymphatic endothelial cells for delivery of therapeutic agents to tumor cells as a means for treating malignant disease, and assays to screen for drugs that modulate lymphatic system expansion, repair or regeneration.
    Type: Application
    Filed: November 7, 2016
    Publication date: April 27, 2017
    Inventors: Zeni Alfonso, John K. Fraser
  • Patent number: 9486484
    Abstract: Aspects of the invention provides methods for preparing and using adipose-tissue-derived stem and progenitor cells, adipose-tissue-derived lymphatic endothelial cells, and cells capable of differentiating into lymphatic endothelial cells to treat disorders of the lymphatic system and to modulate expansion, repair, and/or regeneration of the lymphatic system. The invention further provides using adipose-tissue-derived lymphatic endothelial cells and cells capable of differentiating into lymphatic endothelial cells for delivery of therapeutic agents to tumor cells as a means for treating malignant disease, and assays to screen for drugs that modulate lymphatic system expansion, repair or regeneration.
    Type: Grant
    Filed: July 21, 2014
    Date of Patent: November 8, 2016
    Assignee: Cytori Therapeutics, Inc.
    Inventors: Zeni Alfonso, John K. Fraser
  • Publication number: 20140369970
    Abstract: Aspects of the invention provides methods for preparing and using adipose-tissue-derived stem and progenitor cells, adipose-tissue-derived lymphatic endothelial cells, and cells capable of differentiating into lymphatic endothelial cells to treat disorders of the lymphatic system and to modulate expansion, repair, and/or regeneration of the lymphatic system. The invention further provides using adipose-tissue-derived lymphatic endothelial cells and cells capable of differentiating into lymphatic endothelial cells for delivery of therapeutic agents to tumor cells as a means for treating malignant disease, and assays to screen for drugs that modulate lymphatic system expansion, repair or regeneration.
    Type: Application
    Filed: July 21, 2014
    Publication date: December 18, 2014
    Inventors: Zeni Alfonso, John K. Fraser
  • Patent number: 8784801
    Abstract: Aspects of the invention provides methods for preparing and using adipose-tissue-derived stem and progenitor cells, adipose-tissue-derived lymphatic endothelial cells, and cells capable of differentiating into lymphatic endothelial cells to treat disorders of the lymphatic system and to modulate expansion, repair, and/or regeneration of the lymphatic system. The invention further provides using adipose-tissue-derived lymphatic endothelial cells and cells capable of differentiating into lymphatic endothelial cells for delivery of therapeutic agents to tumor cells as a means for treating malignant disease, and assays to screen for drugs that modulate lymphatic system expansion, repair or regeneration.
    Type: Grant
    Filed: February 18, 2011
    Date of Patent: July 22, 2014
    Assignee: Cytori Therapeutics, Inc.
    Inventors: Zeni Alfonso, John K. Fraser
  • Publication number: 20110206646
    Abstract: Aspects of the invention provides methods for preparing and using adipose-tissue-derived stem and progenitor cells, adipose-tissue-derived lymphatic endothelial cells, and cells capable of differentiating into lymphatic endothelial cells to treat disorders of the lymphatic system and to modulate expansion, repair, and/or regeneration of the lymphatic system. The invention further provides using adipose-tissue-derived lymphatic endothelial cells and cells capable of differentiating into lymphatic endothelial cells for delivery of therapeutic agents to tumor cells as a means for treating malignant disease, and assays to screen for drugs that modulate lymphatic system expansion, repair or regeneration.
    Type: Application
    Filed: February 18, 2011
    Publication date: August 25, 2011
    Inventors: Zeni Alfonso, John K. Fraser